Experimental drug prevents vaginal simian HIV transmission in monkeys Science study says

Potentially important insights for understanding vaginal transmission of HIV and designing new HIV prevention strategies may come from a new SHIV study in monkeys. Scientists coated the vaginal surfaces of monkeys with an experimental drug 15 minutes before exposure to the immunodeficiency virus SHIV and report that the drug protected the animals from infection.

SHIV provides a monkey model for HIV; it contains the inner parts of the simian immunodeficiency virus (SIV) and the outer parts of HIV. This study is published in the 15 October issue of the journal Science published by AAAS the nonprofit science society.

The experimental drug is a chemically synthesized protein called PSC-RANTES, designed by Science coauthors Robin Offord and Oliver Hartley from the University of Geneva in Geneva, Switzerland. It acts by preventing SHIV (and, when human cells are concerned, HIV) from latching on to cell-surface receptors called CCR5. Although in some settings, HIV may use other receptors to get into cells, the success of PSC-RANTES against SHIV in these experiments suggests that CCR5-inhibition -- alone or coupled with other approaches -- might prevent sexual HIV transmission between humans, according to the authors.

The majority of HIV infections are acquired via transmission across mucosal surfaces, especially the vagina and rectum, and substances that prevent mucosal transmission (commonly called microbicides) are urgently needed, the authors write.

"We have identified a key target for strategies to prevent vaginal HIV transmission and have a candidate molecule that blocks this target," said Science author Michael Lederman from Case Western Reserve University in Cleveland, Ohio.

"There is a real need for a topical HIV prevention strategy that women can control. This is particularly important in settings where men won't necessarily use condoms," Lederman said.

Moving from a candidate molecule to a to

Contact: Jessica Lawrence-Hurt
American Association for the Advancement of Science

Page: 1 2 3

Related biology news :

1. 38 minority scientists receive travel fellowships to Experimental Biology 2007 in D.C.
2. Experimental Biology 2007: Todays Research, Tomorrows Health, April 28-May 2
3. Experimental Biology 2007 meets in Washington, D.C., April 28-May 2
4. Experimental cancer drugs counter muscle deterioration seen in muscular dystrophy
5. Experimental RNA-based drug kills prostate cancer cells effectively and safely
6. Experimental vaccine protects nonhuman primates when given after exposure to Marburg virus
7. Undergrads compete for American Physiological Society Bruce awards at Experimental Biology
8. Experimental drug reverses key cognitive deficits, pathology in Alzheimers
9. Experimental TB drug effective against resistant and latent mycobacterium tuberculosis
10. Experimental evolution of yeast in the lab may illuminate early events in speciation
11. Advancing the biomedical frontier: Experimental Biology 2006

Post Your Comments:

(Date:5/28/2020)... ... 2020 , ... Today bioinformatics leader hc1® announced ... lab testing insights and hc1’s exclusive Local Risk Index in a unified CV19 ... employees returning to the workplace. , “Some of the best ways to keep ...
(Date:5/25/2020)... Kingdom (PRWEB) , ... May 22, 2020 , ... Oxford ... for the detection of SARS-CoV-2, the virus that causes COVID-19. , The ... on-demand analysis of smaller sample numbers, to very large numbers of samples. Hardware ...
(Date:5/21/2020)... (PRWEB) , ... May 20, 2020 , ... Law Enforcement ... remove danger for all of us. The positions of these men and women put ... the defense for not following rules precisely. Officers have always had to face very ...
Breaking Biology News(10 mins):
(Date:7/7/2020)... ... July 06, 2020 , ... Bio-IT World has announced the ... Squibb, the University of Chicago, Massachusetts General Hospital, Mission: Cure, and the Pistoia ... program, highlighting outstanding examples of how technology innovations and strategic initiatives can be ...
(Date:6/28/2020)... ... June 25, 2020 , ... The Indoor Lab, a leading provider of ... businesses of all types to ensure cleanliness, distancing and occupancy with its patent pending ... Space™ enabled business will provide a health performance index system that scores all aspects ...
(Date:6/23/2020)... ... 23, 2020 , ... Kerafast Inc. , developers of ... the availability of the Delta-G-VSV Pseudotyping System for coronavirus research applications. The system, ... SARS-CoV-2 viral entry and COVID-19 vaccine effectiveness at just biosafety level 2 (BSL-2) ...
(Date:6/23/2020)... ... June 23, 2020 , ... Nobilis ... announced that it has filed an Investigational New Drug application (IND) with the ... of its lead drug candidate NBTX-001 in patients with panic disorder (PD). , ...
Breaking Biology Technology:
Cached News: